Projects
The pharmaceutical projects listed in this phase are those that receive periodic global announcements.
Major Investment of Over 50 Billion Yen Allocated to Strengthen Bio Manufacturing Facilities and Support Swift Launch of In-House Projects
Chugai Pharmaceutical Co, Ltd TOKYO 4519 will invest 50 billion yen to construct new bio APIs and injection buildings at the Utsunomiya Plant, strengthening its manufacturing capabilities
Aurigene Pharmaceutical Services Expanding Biologics CDMO Capacity with New Biomanufacturing Facility
Aurigene Pharmaceutical Services Limited, a subsidiary of Dr Reddys Laboratories, invests $40 million to construct a new development and manufacturing facility
Boehringer Invests US$285 million in New Chemical Innovation Plant in Germany
Boehringer Ingelheim invests US$285 million investment for a new chemical Innovation Plant at Ingelheim, Germany headquarters
Lilly Invests US$1.5 billion for Manufacturing Facilities Expansion in USA
Lilly has announced a significant investment of US$15 billion in new manufacturing facilities located in North Carolina, Indiana, and Ireland
BeiGene Invests US$700 million in Manufacturing, R&D Facility in USA
BeiGene is investing US$700 million for the construction of its manufacturing, and RD facility in New Jersey, USA
Meissner to Build New Manufacturing Facility in USA
Meissner Corporation has invested US$250 million in the development of a new manufacturing site in AthensClarke County, Georgia, USA
Aytu BioPharma Subleases a Portion of Its Manufacturing Facility in USA
Aytu BioPharma and AMT Manufacturing Solutions have recently reached an agreement regarding the subleasing of a portion of Aytus manufacturing facility located in Grand Prairie, Texas, in the United States
Amgen to Start Construction of a New Bio Manufacturing Facility in the USA
Amgen, a biotechnology leader, has announced plans to construct a new biomanufacturing facility in Holly Springs, North Carolina, USA
Samsung Biologics to Start Construction of a New US$ 1billion Manufacturing Plant
Samsung Biologics has announced that it will invest US$1 billion in the construction of its manufacturing plant at the Songdo site in South Korea
Takeda Invests US$764 million for Plasma-Derived Manufacturing Facility in Japan
Takeda, a global pharmaceutical and biotechnology leader, is investing US$764 million to build a new manufacturing facility for plasmaderived therapies PDTs in Osaka, Japan
